Literature DB >> 31983280

Investigation of the effect of salt additives in Protein L affinity chromatography for the purification of tandem single-chain variable fragment bispecific antibodies.

Serene W Chen1, Darryl Tan1, Yuan Sheng Yang2, Wei Zhang1.   

Abstract

Tandem single-chain variable fragment (scFv) bispecific antibodies (bsAb) are one of the most promising bsAb formats reported thus far. Yet, because of their increased aggregation propensity, high impurity content due to low expression level, smaller size and lack of the Fc region, it is challenging to isolate these products with high yield and purity within a limited number of purification steps in a scalable fashion. A robust purification process that is able to circumvent these issues is therefore of critical importance to allow effective isolation of this group of antibodies. We investigated the addition of sodium chloride (NaCl), calcium chloride (CaCl2), and L-arginine monohydrochloride (Arg·HCl) to the elution buffer of Protein L affinity chromatography, and propose here a novel mechanism for the modification of Protein L binding avidity that can lead to enhanced high molecular weight (HMW)-monomer separation, a preferential strengthening effect of the HMW-Protein L interaction compared to the monomer-Protein L interaction. In particular, we found Arg·HCl to be the most effective salt additive in terms of purity and recovery. The mechanism we propose is different from the widely reported chaotropic effect exerted by salt additives observed in Protein A chromatography. We also demonstrate here that a final eluate containing <1% HMW species and <100 ppm host cell proteins can be obtained within a two-step process with an overall yield of 65%, highlighting the promising suitability of Protein L affinity chromatography for the purification of kappa light chain-containing tandem scFv bsAb.

Entities:  

Keywords:  Bispecific antibody; L-Arginine monohydrochloride; affinity chromatography; high molecular weight; purification; tandem single-chain variable fragment

Mesh:

Substances:

Year:  2020        PMID: 31983280      PMCID: PMC6999846          DOI: 10.1080/19420862.2020.1718440

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  35 in total

1.  A recombinant bispecific single-chain antibody, CD19 x CD3, induces rapid and high lymphoma-directed cytotoxicity by unstimulated T lymphocytes.

Authors:  A Löffler; P Kufer; R Lutterbüse; F Zettl; P T Daniel; J M Schwenkenbecher; G Riethmüller; B Dörken; R C Bargou
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

2.  Bispecific antibodies rise again.

Authors:  Ken Garber
Journal:  Nat Rev Drug Discov       Date:  2014-11       Impact factor: 84.694

3.  Nile red as a polarity-sensitive fluorescent probe of hydrophobic protein surfaces.

Authors:  D L Sackett; J Wolff
Journal:  Anal Biochem       Date:  1987-12       Impact factor: 3.365

4.  Purification of antibodies using protein L-binding framework structures in the light chain variable domain.

Authors:  B H Nilson; L Lögdberg; W Kastern; L Björck; B Akerström
Journal:  J Immunol Methods       Date:  1993-08-26       Impact factor: 2.303

5.  Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infection.

Authors:  Jochen Pendzialek; Kenny Roose; Anouk Smet; Bert Schepens; Peter Kufer; Tobias Raum; Patrick A Baeuerle; Markus Muenz; Xavier Saelens; Walter Fiers
Journal:  Antiviral Res       Date:  2017-03-01       Impact factor: 5.970

6.  Cloned transgenic farm animals produce a bispecific antibody for T cell-mediated tumor cell killing.

Authors:  Ludger Grosse-Hovest; Sigrid Müller; Rosa Minoia; Eckhard Wolf; Valeri Zakhartchenko; Hendrik Wenigerkind; Caroline Lassnig; Urban Besenfelder; Mathias Müller; Simon D Lytton; Gundram Jung; Gottfried Brem
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-22       Impact factor: 11.205

Review 7.  Bispecific T-cell engaging antibodies for cancer therapy.

Authors:  Patrick A Baeuerle; Carsten Reinhardt
Journal:  Cancer Res       Date:  2009-06-09       Impact factor: 12.701

8.  A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.

Authors:  M Mack; G Riethmüller; P Kufer
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 9.  Arginine-enveloped virus inactivation and potential mechanisms.

Authors:  Christa Meingast; Caryn L Heldt
Journal:  Biotechnol Prog       Date:  2019-11-11

10.  Development of purification processes for fully human bispecific antibodies based upon modification of protein A binding avidity.

Authors:  Andrew D Tustian; Christine Endicott; Benjamin Adams; John Mattila; Hanne Bak
Journal:  MAbs       Date:  2016-03-10       Impact factor: 5.857

View more
  4 in total

1.  Mass Spectrometry-Based Methods for Immunoglobulin G N-Glycosylation Analysis.

Authors:  Siniša Habazin; Jerko Štambuk; Jelena Šimunović; Toma Keser; Genadij Razdorov; Mislav Novokmet
Journal:  Exp Suppl       Date:  2021

2.  Development of a T cell-redirecting bispecific antibody targeting B-cell maturation antigen for the suppression of multiple myeloma cell growth.

Authors:  Jianxin Huo; Yuhan Huang; Ziying Zheng; Xin Ni Tay; Farouq Bin Mahfut; Wei Zhang; Kong-Peng Lam; Yuansheng Yang; Shengli Xu
Journal:  Antib Ther       Date:  2022-06-09

Review 3.  Current trends and challenges in the downstream purification of bispecific antibodies.

Authors:  Serene W Chen; Wei Zhang
Journal:  Antib Ther       Date:  2021-05-07

4.  Continuous Affinity Purification of Adeno-Associated Virus Using Periodic Counter-Current Chromatography.

Authors:  João P Mendes; Magnus Bergman; Anita Solbrand; Cristina Peixoto; Manuel J T Carrondo; Ricardo J S Silva
Journal:  Pharmaceutics       Date:  2022-06-25       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.